Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
Status:
Terminated
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This is a single center, prospective, randomized, unblinded, open-label, active controlled
pilot study to evaluate the efficacy and safety of ticagrelor plus aspirin versus clopidogrel
plus aspirin in patients with Rutherford Stage IV to VI PAD that have undergone a
percutaneous transluminal angioplasty (PTA) of the lower extremities in the past 2 weeks.